Epithelioid sarcoma other diagnostic studies

	Epithelioid sarcoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Epithelioid sarcoma from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
MRI
Other Diagnostic Studies
Biopsy
Treatment
Medical Therapy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Epithelioid sarcoma other diagnostic studies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Epithelioid sarcoma other diagnostic studies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Epithelioid sarcoma other diagnostic studies
CDC on Epithelioid sarcoma other diagnostic studies
Epithelioid sarcoma other diagnostic studies in the news
Blogs on Epithelioid sarcoma other diagnostic studies
Directions to Hospitals Treating Epithelioid sarcoma
Risk calculators and risk factors for Epithelioid sarcoma other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Loss of INI1 (also known as hSNF5 and SMARCB1) which is a member of SWI/SNF multi subunit chromatin remodeling complex located on the long arm of chromosome 22 (22q11.2) has been a diagnostic modalty of epithelioid sarcoma.
Immunohistochemical staining of INI1 is available and can be used for the diagnosis of epithelioid sarcoma. MRI is the diagnostic modality of choice for imaging prior to biopsy and pathologic diagnosis, with the primary role being the determination of anatomic boundaries.